Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New Data Supports Pharmacoeconomic Benefits of Ceplene® TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announces the release of new findings...
-
EpiCept's Ceplene® Highlighted in Two 2008 European Union Drug Approval Reports TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that...
-
EpiCept Corporation to Present at the Rodman & Renshaw Healthcare Conference TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Jack...
-
EpiCept Corporation Reports Second Quarter 2009 Operating and Financial Results, Provides Business Update Conference Call Begins at 9:00 a.m. Eastern Time Today TARRYTOWN, N.Y.--(BUSINESS WIRE)--...
-
EpiCept Announces Filing of New Drug Submission for Approval of Ceplene in Canada TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it...
-
EpiCept to Report Second Quarter 2009 Operating and Financial Results on August 6, 2009 TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange:...
-
EpiCept Initiates Post-Approval Clinical Study with Ceplene® Further Evidence of Efficacy for Ceplene ® in Patients with AML Will Be Assessed by Measuring Biomarkers and Minimal Residual Disease...
-
EpiCept Announces Results of Annual Meeting of Stockholders TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today...
-
EpiCept Shares on the OMX Nordic Exchange Transferred Back to Ordinary Position from Observation Segment TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange:...
-
EPICEPT ANNOUNCES PRICING OF PUBLIC OFFERING TARRYTOWN, N.Y. (June 19, 2009) - EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that it entered into definitive agreements...